Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating ERLEADA® without docetaxel ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...

A dose reduction of Erleada may result in fewer skin-related side effects for men with advanced prostate cancer — but only for those with a smaller body size, research showed. A dose reduction of ...

In late March 2020, my pregnant daughter-in-law and I compared health issues. Hot flashes? Check. Acidity? Yes. Sore breasts? That, too. Brain fog? You bet. Fatigue? Insomnia? Thinning hair? We both ...

Salvage radiation to the prostate bed and pelvic lymph nodes is the standard approach to treating biochemical recurrence. The concurrent use of antiandrogen therapy with radiation therapy has also ...

The use of prostate-specific antigen (PSA) testing for prostate cancer screening remains the subject of scientific debate. Experts are unable to agree on how to balance the benefit of such testing ...

Observational data suggested that men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle. A higher prostate cancer behavior score was associated with reductions in ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

Three-dimensional ultrasound-based spectroscopic imaging for the detection of prostate cancer. Background: We previously reported that physical activity may reduce prostate cancer (CaP) risk among men ...